Can I read Safety of GO With Cytaara, Dauno, Midostaurin in FLT3 Mutated AML on EtoBox?

Safety of GO With Cytaara, Dauno, Midostaurin in FLT3 Mutated AML by Indira Chowdhury is a document available to read on EtoBox.

What is Safety of GO With Cytaara, Dauno, Midostaurin in FLT3 Mutated AML about?

This phase 1 study evaluated the safety and efficacy of adding gemtuzumab ozogamicin (GO) to standard chemotherapy in 21 patients with newly diagnosed FLT3-mutated acute myeloid leukemia (AML). The combination was well tolerated, with 76% of patients achieving a composite complete response after induction therapy, and the maximum tolerated dose was established. The findings suggest that GO can be safely integrated into treatment regimens for this patient population, potentially improving outcomes.

Author

Indira Chowdhury

Language

EN